ESC 365 - False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study

ESC Professional Premium Access

False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study

Session: Cardiovascular risk assessment

Topic: Biomarkers

Speaker: Doctor E. Kaplan (Basel, CH)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Emel Kaplan

Cardiovascular Research Institute Basel, Basel (Switzerland)

0 follower

3 more presentations in this session

Prevalence and prognostic implication of left ventricular hypertrophy defined by different echocardiographic criteria

Speaker: Doctor A. Cai (Guangzhou, CN)

Identification of premature cardiovascular disease using a family-based strategy: a feasibility pilot study

Speaker: Mr P. Charleux (Paris, FR)

Predictors of cardiovascular disease risk: findings from the National Survey of Health and Development Cohort.

Speaker: Doctor E. Agwara (Cambridge, GB)

Access the full session

Cardiovascular risk assessment

Speakers: Doctor E. Kaplan, Doctor A. Cai, Mr P. Charleux, Doctor E. Agwara

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources